Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer

Published:2019-02-06 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Yeong Joe,Lim Jeffrey Chun Tatt,Lee Bernett,Li Huihua,Ong Clara Chong Hui,Thike Aye Aye,Yeap Wei Hseun,Yang Yi,Lim Ansel Yi Herh,Tay Timothy Kwang Yong,Liu Jin,Wong Siew-Cheng,Chen Jinmiao,Lim Elaine Hsuen,Iqbal Jabed,Dent Rebecca,Newell Evan W.,Tan Puay Hoon

Funder

A*STAR Biomedical Research Council, National Medical Research Council Stratified Medicine Programme Office

SingHealth Duke-NUS Pathology Academic Clinical Program Budding Clinician-Scientist grant

Singapore National Medical Research Council

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-019-0499-y.pdf

Reference126 articles.

1. Thike AA, Cheok PY, Jara-Lazaro AR, Tan B, Tan P, Tan PH. Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol. 2009;23(1):123–33.

2. Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. DIfferences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2):165–73.

3. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast Cancer. New Engl J Med. 2010;363(20):1938–48.

4. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15 Pt 1):4429–34.

5. Kassam F, Enright K, Dent R, Dranitsaris G, Myers J, Flynn C, et al. Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design. Clin Breast Cancer. 2009;9(1):29–33.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of immunotherapy responsiveness in melanoma through single-cell sequencing-based characterization of the tumor immune microenvironment;Translational Oncology;2024-05

2. Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes;Cancer Immunology, Immunotherapy;2024-02-13

3. Review of immune checkpoint blockade and PD-L1 testing in breast cancer;Diagnostic Histopathology;2024-02

4. Strategies for studying immune and non-immune human and canine mammary gland cancer tumour infiltrate;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01

5. Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer;OncoImmunology;2023-12-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3